Evidence map›Paper›PMID 27465218›Full record

ArticleJournal of virological methods2016

Full inactivation of alphaviruses in single particle and crystallized forms.

Robert M Lawrence, James D Zook, Brenda G Hogue

Abstract read
In one paragraph

Article in Journal of virological methods, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Journal of photochemistry and photobiology · 2022
    Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Robert M LawrenceBiodesign Institute, Tempe, AZ 85287, USA; Biodesign Center for Infectious Diseases and Vaccinology, Tempe, AZ 85287, USA; Biodesign Center for Applied Structural Discovery, Tempe, AZ 85287, USA.
James D ZookBiodesign Center for Applied Structural Discovery, Tempe, AZ 85287, USA; School of Molecular Sciences, Tempe, AZ 85287, USA.
Brenda G HogueBiodesign Institute, Tempe, AZ 85287, USA; Biodesign Center for Infectious Diseases and Vaccinology, Tempe, AZ 85287, USA; Biodesign Center for Applied Structural Discovery, Tempe, AZ 85287, USA; School of Life Sciences, Arizona State University, Tempe, AZ 85287, USA. Electronic address: Brenda.Hogue@asu.edu.
Arizona State University · US

Funding

Center for the Rational Design of Membrane Protein CrystallographyU54GM094599 · NIGMS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI FROMME, PETRA · 2010 to 2014
$6.8M
Isolating Viral Particles from Whole BloodR03AI094193 · NIAID · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI HAYES, MARK A, HOGUE, BRENDA G. · 2012 to 2013
$138k
Pathogen Isolation and Concentration for Phenotypic SubtypingR03AI099740 · NIAID · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI HAYES, MARK A · 2012 to 2013
$138k
Isolation of Pathogenic ListeriaR03AI111361 · NIAID · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI HAYES, MARK A · 2015 to 2016
$136k
NIAID NIH HHS R03 AI094193NIAID NIH HHS R03 AI099740NIAID NIH HHS R03 AI111361NIGMS NIH HHS U54 GM094599
6 · The paper itself

Abstract

Inherent in the study of viruses is the risk of pathogenic exposure, which necessitates appropriate levels of biosafety containment. Unfortunately, this also limits the availability of useful research instruments that are located at facilities not equipped to handle infectious pathogens. Abrogation of viral infectivity can be accomplished without severely disrupting the physical structure of the virus particle. Virus samples that are verifiably intact but not infectious may be enabled for study at research facilities where they would otherwise not be allowed. Inactivated viruses are also used in the development of vaccines, where immunogenicity is sought in the absence of active infection. We demonstrate the inactivation of Sindbis alphavirus particles in solution, as well as in crystallized form. Inactivation was accomplished by two different approaches: crosslinking of proteins by glutaraldehyde treatment, and crosslinking of nucleic acids by UV irradiation. Biophysical characterization methods, including dynamic light scattering and transmission electron microscopy, were used to demonstrate that the glutaraldehyde and UV inactivated Sindbis virus particles remain intact structurally. SDS-PAGE was also used to show evidence of the protein crosslinking that was expected with glutaraldehyde treatment, but also observed with UV irradiation.

Indexed as

CrystallizationVirus InactivationCross-Linking ReagentsDisinfectantsDynamic Light ScatteringElectrophoresis, Polyacrylamide GelGlutaralMicroscopy, Electron, TransmissionSindbis VirusUltraviolet RaysVirionCross-Linking ReagentsDisinfectantsGlutaralCrystallizationGlutaraldehydeSindbisSingle particleUV irradiationVirus inactivation

Identifiers

PMID27465218
PMCPMC6457655
OpenAlexW2491268805

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.